Completed PHASE1 INTERVENTIONAL 2-arm NCT03350386

Drug-drug Interaction Study of FYU-981 and Oxaprozin

Drug-drug Interaction Study to Evaluate the Pharmacokinetics and Safety of FYU-981 and Oxaprozin in Healthy Male Adults Subjects

Sponsor: Fuji Yakuhin Co., Ltd.

Conditions Healthy

Interventions FYU-981 Oxaprozin

Updated 6 times since 2017 Last updated: Sep 9, 2022 Started: Nov 2, 2017 Primary completion: Dec 5, 2017 Completion: Dec 5, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Fuji Yakuhin Co., Ltd. and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Sep 2022 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Sep 2022 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Data source: Mochida Pharmaceutical Company, Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hachiōji, Japan